{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:08:41Z","timestamp":1788880121245,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ejogrb.2011.07.001","type":"journal-article","created":{"date-parts":[[2011,8,14]],"date-time":"2011-08-14T14:38:00Z","timestamp":1313332680000},"page":"394-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma"],"prefix":"10.1016","volume":"159","author":[{"given":"Kenji","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Yonemori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Katsumata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taizo","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harukaze","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2011.07.001_bib0005","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/1097-0142(19890401)63:7<1337::AID-CNCR2820630719>3.0.CO;2-J","article-title":"Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix","volume":"63","author":"Crombach","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2011.07.001_bib0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1200\/JCO.1996.14.1.111","article-title":"Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma","volume":"14","author":"Duk","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2011.07.001_bib0015","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1200\/JCO.1994.12.11.2309","article-title":"Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer","volume":"12","author":"Scambia","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2011.07.001_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.critrevonc.2007.09.002","article-title":"The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature","volume":"66","author":"Gadducci","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejogrb.2011.07.001_bib0025","unstructured":"World Health Organization. WHO handbook for reporting result of cancer treatment. Offset publication 48. Geneva: World Health Organization; 1979."},{"key":"10.1016\/j.ejogrb.2011.07.001_bib0030","unstructured":"International Agency for Research on Cancer. WHO Chron 1969;23:323\u20136."},{"key":"10.1016\/j.ejogrb.2011.07.001_bib0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.ejogrb.2011.07.001_bib0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0090-8258(89)90056-5","article-title":"Use of serum squamous cell carcinoma antigen assays in chemotherapy treatment of cervical cancer","volume":"35","author":"Ngan","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2011.07.001_bib0045","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0360-3016(98)00147-3","article-title":"The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy","volume":"41","author":"Hong","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejogrb.2011.07.001_bib0050","first-page":"5113","article-title":"The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer","volume":"20","author":"Micke","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejogrb.2011.07.001_bib0055","first-page":"781","article-title":"Assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging","volume":"100","author":"Ohara","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2011.07.001_bib0060","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.ygyno.2007.07.033","article-title":"Biochemical prognostic factors and risk of relapses in patients with cervical cancer","volume":"107","author":"Gadducci","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2011.07.001_bib0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0360-3016(01)01805-3","article-title":"Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment","volume":"52","author":"Pras","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejogrb.2011.07.001_bib0070","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0090-8258(89)90164-9","article-title":"Value of squamous cell carcinoma antigen levels in invasive cervical carcinoma","volume":"34","author":"Maiman","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2011.07.001_bib0075","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2001.19.20.4054","article-title":"Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels","volume":"19","author":"Rustin","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2011.07.001_bib0080","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","article-title":"Early versus delayed treatment of relapsed ovarian cancer (MRC OV05\/EORTC 55955): a randomised trial","volume":"376","author":"Rustin","year":"2010","journal-title":"Lancet"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211511004027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211511004027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:29:43Z","timestamp":1788877783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211511004027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0301211511004027"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2011.07.001","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2011.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}